Papers: 3 Jan 2014 - 10 Jan 2014
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats.
Tolerogenic dendritic cells produced by Lentiviral-mediated CD40- and IL-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing Th17 cells.
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
Unusual case of gastroparesis leading to severe gastromegaly with demyelinating disease as a rare cause.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay.
Evaluation of Lovastatin Effects on Expression of Anti-apoptotic Nrf2 and PGC-1α Genes in Neural Stem Cells Treated with Hydrogen Peroxide.
SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.
Correction: Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases.
Identification of Tmem10 as a Novel Late-stage Oligodendrocytes Marker for Detecting Hypomyelination.